Patents by Inventor Andy Ying
Andy Ying has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240119538Abstract: A method and apparatus is described for performing transaction tracing. The method may include mapping one or more funds flow transactions into each account to one or more funds flow transactions out of said each account based on a first-in-first-out ordering. The method may also include generating an initial graph from the mappings of the transactions for each said account. Furthermore, the method may include transforming the initial graph to a function graph, wherein the functional graph is a directed pseudoforest where each node has an out degree of at most one. Then, the method may include for a node in the functional graph, performing a trace of the transaction generating a set of transactions that contributed to the transaction.Type: ApplicationFiled: December 4, 2023Publication date: April 11, 2024Inventors: Robert Ying, Cale Horeff, Miguel Flores, Jeremiah Clemenson, Andy Zhang
-
Patent number: 10968487Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: GrantFiled: April 4, 2018Date of Patent: April 6, 2021Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Publication number: 20180223377Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: ApplicationFiled: April 4, 2018Publication date: August 9, 2018Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Patent number: 9938584Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: GrantFiled: January 31, 2017Date of Patent: April 10, 2018Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Publication number: 20170137894Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: ApplicationFiled: January 31, 2017Publication date: May 18, 2017Applicant: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Patent number: 9605321Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: GrantFiled: December 12, 2014Date of Patent: March 28, 2017Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Publication number: 20150094231Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: ApplicationFiled: December 12, 2014Publication date: April 2, 2015Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Jill Detmer, Arejas J. Uzgiris, Andy Ying
-
Patent number: 8940486Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: GrantFiled: January 4, 2011Date of Patent: January 27, 2015Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Jill Detmer, Arejas Uzgiris, Andy Ying
-
Publication number: 20120288863Abstract: Provided are oligonucleotides that are capable of detecting KRAS and PIK3CA mutations in both cancer patients and healthy individuals with high specificity in kPCR assays. When the oligonucleotides are used as forward primers in conjunction with a defined genotyping algorithm spreadsheet, the primers are capable of enhancing detection of KRAS codon 12, 13, and 61 and PIK3CA codon 542, 545, and 1047 single nucleotide polymorphisms (SNPs) in a background of wild-type sequences. The oligonucleotides of the present invention are also capable of preventing pseudogene amplification when the oligonucleotides are hybridized as reverse primers or detection probes to the mismatch sequences.Type: ApplicationFiled: January 4, 2011Publication date: November 15, 2012Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Jill Detmer, Arejas Uzgiris, Andy Ying
-
Publication number: 20120086846Abstract: An interface system of an image-capturing device is disclosed, which is set on a hand-held image-capturing device. The interface system of an image-capturing device includes a display unit, a touch sensor unit, and a control unit. The display unit displays a variety of setting pictures of the image-capturing device. The touch sensor unit senses a touch of a user so as to change the setting pictures displayed on the display unit. The control unit is connected with the display unit and the touch sensor unit, for controlling the operation of the image-capturing device. The disclosed interface system of an image-capturing device enables the user to adjust various kinds of exposure parameters quickly and intuitively.Type: ApplicationFiled: March 30, 2011Publication date: April 12, 2012Applicant: National Cheng Kung UniversityInventors: Andy Ying-Guey Fuh, Cheng-Kai Liu
-
Publication number: 20100255482Abstract: The present invention relates to oligonucleotide sequences for amplification primers and detection probes and to their use in nucleic acid amplification methods for the detection of HBV in biological samples. In particular, oligonucleotide sequences are provided for the sensitive qualitative or quantitative detection of all eight HBV genotypes. The invention also provides oligonucleotide primer sets and primer/probe sets in the form of kits for the diagnosis of HBV infection.Type: ApplicationFiled: October 29, 2008Publication date: October 7, 2010Applicant: SIEMENS HEALTHCARE DIAGNOSTICS INC.Inventors: Lu-ping Shen, Carrie Li Wong, Lailing Ku, Andy Ying, Charlene Bush-Donovan